Viewing Study NCT00005032


Ignite Creation Date: 2025-12-24 @ 9:33 PM
Ignite Modification Date: 2026-01-21 @ 8:05 AM
Study NCT ID: NCT00005032
Status: COMPLETED
Last Update Posted: 2013-02-11
First Post: 2000-04-06
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Bcl-2 Antisense Oligodeoxynucleotide G3139 and Paclitaxel in Treating Patients With Recurrent Small Cell Lung Cancer
Sponsor: University of Chicago
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 10117
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None NIH View